Rapid Review Quiz: Hospital-Acquired Pneumonia

September 15, 2022

A recent meta-analysis including 23 trials and 5543 patients found that administering prophylactic probiotic therapy demonstrated a 31% decreased risk for VAP among adult patients compared with placebo groups. No differences were seen between the groups in ICU/hospital 28- and 90-day mortality or incidence of wound infection, catheter-related bloodstream infection, bacteremia, ICU-acquired infections, diarrhea, infectious complications, and UTI.

Learn more about hospital-acquired infections.

This Rapid Review Quiz was excerpted and adapted from the Medscape articles: US Deaths from Antibiotic Resistant 'Superbugs' Rose 15% in 2020, Hospital-Acquired Pneumonia (Nosocomial Pneumonia) and Ventilator-Associated Pneumonia, Ventilator-Associated Pneumonia Overview of Nosocomial Pneumonias, Meropenem-Vaborbactam, Doripenem, and Hospital-Acquired Infections.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.